96 related articles for article (PubMed ID: 2258187)
1. Spontaneous fusion between splenocytes and myeloma cells induced by bacterial immunization.
Verschoor JA; Boshoff CH; Coetzee L; Van Wyngaardt S; Visser L
Hybridoma; 1990 Oct; 9(5):511-8. PubMed ID: 2258187
[TBL] [Abstract][Full Text] [Related]
2. Spontaneous hybridoma formation induced by immunization with Haemophilus paragallinarum: evidence for a lipopolysaccharide fusion inducer.
Boshoff CH; Coetzee L; Visser L; Verschoor JA
Hybridoma; 1992 Apr; 11(2):257-66. PubMed ID: 1607214
[TBL] [Abstract][Full Text] [Related]
3. Hybridoma Technology.
Hnasko RM; Stanker LH
Methods Mol Biol; 2015; 1318():15-28. PubMed ID: 26160560
[TBL] [Abstract][Full Text] [Related]
4. Development of mouse hybridomas by fusion of myeloma cells with lymphocytes derived from spleen, lymph node, and bone marrow.
Başalp A; Yücel F
Hybrid Hybridomics; 2003 Oct; 22(5):329-31. PubMed ID: 14678651
[TBL] [Abstract][Full Text] [Related]
5. Rat hybridoma technology: culturing of rat myeloma cell line IR983F prior to cell fusion.
Lebacq-Verheyden AM; Neirynck A; Ravoet AM; Bazin H
Hybridoma; 1983; 2(3):355-8. PubMed ID: 6678801
[TBL] [Abstract][Full Text] [Related]
6. Production of monoclonal antibodies to a tumor--associated antigen by spontaneous cell fusion.
Subbiah K; Ananthanarayanan M
Indian J Cancer; 2000 Mar; 37(1):15-22. PubMed ID: 11261231
[TBL] [Abstract][Full Text] [Related]
7. Influence of antigen presentation and exogenous cytokine activity during in vitro primary immunizations employed for the generation of monoclonal antibodies.
Halabi G; McCullough KC
J Immunol Methods; 1995 Oct; 186(2):205-16. PubMed ID: 7594620
[TBL] [Abstract][Full Text] [Related]
8. Hybridoma-free generation of monoclonal antibodies.
Pasqualini R; Arap W
Proc Natl Acad Sci U S A; 2004 Jan; 101(1):257-9. PubMed ID: 14688405
[TBL] [Abstract][Full Text] [Related]
9. Fusion of myeloma cells with immune spleen cells.
Fuller SA; Takahashi M; Hurrell JG
Curr Protoc Mol Biol; 2001 May; Chapter 11():Unit11.7. PubMed ID: 18265079
[TBL] [Abstract][Full Text] [Related]
10. [A new approach to the design of hybrid hybridomas based on the use of an actinomycin D-resistant line of murine myeloma].
Massino IuS; Kizim EA; Dmitriev AD
Biull Eksp Biol Med; 1991 Nov; 112(11):511-4. PubMed ID: 1687361
[TBL] [Abstract][Full Text] [Related]
11. Hybridoma generation by in vitro immunization of murine splenocytes with cytosolic proteins of Chinese hamster ovary (CHO) mitotic cells.
Ravi M; Sundar SS; Kumar KK; Parvathi D; Paul SF
Hybridoma (Larchmt); 2007 Oct; 26(5):311-5. PubMed ID: 17979547
[TBL] [Abstract][Full Text] [Related]
12. Monoclonal Antibodies Against Porcine sIgA and Their Use in Immunohistochemistry.
Song W; Feng Z; Bai Y; Wang H; Ishag HZ; Yang R; Hua L; Chen C; Zhang Z; Shu C; Liu M; Xiong Q; Shao G
Monoclon Antib Immunodiagn Immunother; 2015 Dec; 34(6):386-9. PubMed ID: 26683177
[TBL] [Abstract][Full Text] [Related]
13. Culture conditions that optimize outgrowth of hybridomas.
Hamilton MJ; Davis WC
Methods Mol Biol; 1995; 45():17-28. PubMed ID: 7550679
[No Abstract] [Full Text] [Related]
14. Improved fusion technique. II. Stability and purity of hybrid clones.
Westerwoudt RJ; Naipal AM; Harrisson CM
J Immunol Methods; 1984 Mar; 68(1-2):89-101. PubMed ID: 6538588
[TBL] [Abstract][Full Text] [Related]
15. The use of an anti-CD40 agonist monoclonal antibody during immunizations enhances hybridoma generation.
Rycyzyn MA; Staquet K; Fisher J; Bannish G; Bassiri A; Duchala C; Giles-Komar J
Hybridoma (Larchmt); 2008 Feb; 27(1):25-30. PubMed ID: 18294073
[TBL] [Abstract][Full Text] [Related]
16. Efficient hybridoma production using previously frozen splenocytes.
Marusich MF
J Immunol Methods; 1988 Nov; 114(1-2):155-9. PubMed ID: 3183388
[TBL] [Abstract][Full Text] [Related]
17. Production of stable heterohybridomas producing human monoclonal antibodies.
Cooper MD; Kirkpatrick R
Methods Mol Biol; 1995; 45():29-39. PubMed ID: 7550689
[No Abstract] [Full Text] [Related]
18. Monoclonal antibodies to rat sarcomata. I. Immunization procedures and source of lymphoid cells for hybridoma production.
North SM; Styles JM; Hobbs SM; Dean CJ
Immunology; 1982 Nov; 47(3):397-405. PubMed ID: 7129525
[TBL] [Abstract][Full Text] [Related]
19. Transfection of NS0 myeloma fusion partner cells with HSP70 gene results in higher hybridoma yield by improving cellular resistance to apoptosis.
Lasunskaia EB; Fridlianskaia II; Darieva ZA; da Silva MS; Kanashiro MM; Margulis BA
Biotechnol Bioeng; 2003 Feb; 81(4):496-504. PubMed ID: 12491534
[TBL] [Abstract][Full Text] [Related]
20. [Use of highly sensitive radioautography for determining the optimal conditions for obtaining hybridomas].
Tsoĭ LA; Kushch AA; Uvarova NV; Novokhatskiĭ AS; Zelenin AV
Ontogenez; 1984; 15(5):556-9. PubMed ID: 6504502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
